Administration of Erythropoietin in Patients With Acute Myocardial Infarction: Good or Not?

Heart - United Kingdom
doi 10.1136/heartjnl-2012-302920j.40
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Erythropoietin-Induced Progenitor Cell Mobilisation in Patients With Acute ST-segment-elevation Myocardial Infarction and Restenosis

Thrombosis and Haemostasis
Hematology
2012English

Atrial Fibrillation in Patients Hospitalized With Acute Myocardial Infarction: Analysis of the China Acute Myocardial Infarction (CAMI) Registry

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2017English

Iron Stores Are Not Associated With Acute Myocardial Infarction

Circulation
Cardiovascular MedicinePhysiologyCardiology
1994English

Comparison of Long-Term Mortality in Patients With Acute Myocardial Infarction Associated With or Without Sepsis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Haemodynamic Effects of Morphine in Patients With Acute Myocardial Infarction

Survey of Anesthesiology
1966English

Biochemical Parameters in Acute Myocardial Infarction With or Without Co-Morbidities

Journal of Medical Science And clinical Research
2017English

Evaluation of Coronary Risk Factors in Patients With Acute Myocardial Infarction

Journal of Evolution of Medical and Dental Sciences
2015English

Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction

Archives of Internal Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy